SRZN DUET study launches for dual VEGF/Wnt therapy in DME
A two-part clinical study for a dual VEGF/Wnt molecule in diabetic macular edema will start this year, focusing on safety, efficacy and unique reperfusion endpoints. Initial data is expected in 2027.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.